Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.

Abstract

BACKGROUND Plasma transforming growth factor-beta1 (TGFbeta1) levels are increased in many malignancies at the time of diagnosis, including all forms of lung carcinoma. Therefore, the potential use of TGFbeta1 as a plasma marker to predict the long term outcome of lung carcinoma patients treated with radiotherapy (RT) was evaluated. METHODS Plasma samples… (More)

Topics

Cite this paper

@article{Kong1999PlasmaTG, title={Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.}, author={Feng Kong and R. L. Jirtle and D. H. Huang and Rich W Clough and Mitchell Steven Anscher}, journal={Cancer}, year={1999}, volume={86 9}, pages={1712-9} }